Biobanking -United States Market Status and Trend Report 2013-2023
Report Summary
Biobanking -United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biobanking industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Biobanking 2013-2017, and development forecast 2018-2023
Main market players of Biobanking in United States, with company and product introduction, position in the Biobanking market
Market status and development trend of Biobanking by types and applications
Cost and profit status of Biobanking , and marketing status
Market growth drivers and challenges
The report segments the United States Biobanking market as:
United States Biobanking Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Biobanking Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Equipment
Consumable
United States Biobanking Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Virtual Biobanks
Tissue Biobanks
Population Biobanks
United States Biobanking Market: Players Segment Analysis (Company and Product introduction, Biobanking Sales Volume, Revenue, Price and Gross Margin):
Thermo Fisher
Beckman Coulter
Panasonic
SOL Group
Promega
Merck
Greiner Bio One
Chart Industries
Brooks Life Science
Tecan Group
QIAGEN
BD
Lifeline Scientific
Hamilton
So-Low
TTP Labtech Ltd
Biolife Solutions
DNA Genotek
Custom Biogenic Systems
LVL Technologies
BioRep
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Biobanking -United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biobanking industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Biobanking 2013-2017, and development forecast 2018-2023
Main market players of Biobanking in United States, with company and product introduction, position in the Biobanking market
Market status and development trend of Biobanking by types and applications
Cost and profit status of Biobanking , and marketing status
Market growth drivers and challenges
The report segments the United States Biobanking market as:
United States Biobanking Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Biobanking Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Equipment
Consumable
United States Biobanking Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Virtual Biobanks
Tissue Biobanks
Population Biobanks
United States Biobanking Market: Players Segment Analysis (Company and Product introduction, Biobanking Sales Volume, Revenue, Price and Gross Margin):
Thermo Fisher
Beckman Coulter
Panasonic
SOL Group
Promega
Merck
Greiner Bio One
Chart Industries
Brooks Life Science
Tecan Group
QIAGEN
BD
Lifeline Scientific
Hamilton
So-Low
TTP Labtech Ltd
Biolife Solutions
DNA Genotek
Custom Biogenic Systems
LVL Technologies
BioRep
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BIOBANKING
1.1 Definition of Biobanking in This Report
1.2 Commercial Types of Biobanking
1.2.1 Equipment
1.2.2 Consumable
1.3 Downstream Application of Biobanking
1.3.1 Virtual Biobanks
1.3.2 Tissue Biobanks
1.3.3 Population Biobanks
1.4 Development History of Biobanking
1.5 Market Status and Trend of Biobanking 2013-2023
1.5.1 United States Biobanking Market Status and Trend 2013-2023
1.5.2 Regional Biobanking Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Biobanking in United States 2013-2017
2.2 Consumption Market of Biobanking in United States by Regions
2.2.1 Consumption Volume of Biobanking in United States by Regions
2.2.2 Revenue of Biobanking in United States by Regions
2.3 Market Analysis of Biobanking in United States by Regions
2.3.1 Market Analysis of Biobanking in New England 2013-2017
2.3.2 Market Analysis of Biobanking in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Biobanking in The Midwest 2013-2017
2.3.4 Market Analysis of Biobanking in The West 2013-2017
2.3.5 Market Analysis of Biobanking in The South 2013-2017
2.3.6 Market Analysis of Biobanking in Southwest 2013-2017
2.4 Market Development Forecast of Biobanking in United States 2018-2023
2.4.1 Market Development Forecast of Biobanking in United States 2018-2023
2.4.2 Market Development Forecast of Biobanking by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Biobanking in United States by Types
3.1.2 Revenue of Biobanking in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Biobanking in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Biobanking in United States by Downstream Industry
4.2 Demand Volume of Biobanking by Downstream Industry in Major Countries
4.2.1 Demand Volume of Biobanking by Downstream Industry in New England
4.2.2 Demand Volume of Biobanking by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Biobanking by Downstream Industry in The Midwest
4.2.4 Demand Volume of Biobanking by Downstream Industry in The West
4.2.5 Demand Volume of Biobanking by Downstream Industry in The South
4.2.6 Demand Volume of Biobanking by Downstream Industry in Southwest
4.3 Market Forecast of Biobanking in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BIOBANKING
5.1 United States Economy Situation and Trend Overview
5.2 Biobanking Downstream Industry Situation and Trend Overview
CHAPTER 6 BIOBANKING MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Biobanking in United States by Major Players
6.2 Revenue of Biobanking in United States by Major Players
6.3 Basic Information of Biobanking by Major Players
6.3.1 Headquarters Location and Established Time of Biobanking Major Players
6.3.2 Employees and Revenue Level of Biobanking Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BIOBANKING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Thermo Fisher
7.1.1 Company profile
7.1.2 Representative Biobanking Product
7.1.3 Biobanking Sales, Revenue, Price and Gross Margin of Thermo Fisher
7.2 Beckman Coulter
7.2.1 Company profile
7.2.2 Representative Biobanking Product
7.2.3 Biobanking Sales, Revenue, Price and Gross Margin of Beckman Coulter
7.3 Panasonic
7.3.1 Company profile
7.3.2 Representative Biobanking Product
7.3.3 Biobanking Sales, Revenue, Price and Gross Margin of Panasonic
7.4 SOL Group
7.4.1 Company profile
7.4.2 Representative Biobanking Product
7.4.3 Biobanking Sales, Revenue, Price and Gross Margin of SOL Group
7.5 Promega
7.5.1 Company profile
7.5.2 Representative Biobanking Product
7.5.3 Biobanking Sales, Revenue, Price and Gross Margin of Promega
7.6 Merck
7.6.1 Company profile
7.6.2 Representative Biobanking Product
7.6.3 Biobanking Sales, Revenue, Price and Gross Margin of Merck
7.7 Greiner Bio One
7.7.1 Company profile
7.7.2 Representative Biobanking Product
7.7.3 Biobanking Sales, Revenue, Price and Gross Margin of Greiner Bio One
7.8 Chart Industries
7.8.1 Company profile
7.8.2 Representative Biobanking Product
7.8.3 Biobanking Sales, Revenue, Price and Gross Margin of Chart Industries
7.9 Brooks Life Science
7.9.1 Company profile
7.9.2 Representative Biobanking Product
7.9.3 Biobanking Sales, Revenue, Price and Gross Margin of Brooks Life Science
7.10 Tecan Group
7.10.1 Company profile
7.10.2 Representative Biobanking Product
7.10.3 Biobanking Sales, Revenue, Price and Gross Margin of Tecan Group
7.11 QIAGEN
7.11.1 Company profile
7.11.2 Representative Biobanking Product
7.11.3 Biobanking Sales, Revenue, Price and Gross Margin of QIAGEN
7.12 BD
7.12.1 Company profile
7.12.2 Representative Biobanking Product
7.12.3 Biobanking Sales, Revenue, Price and Gross Margin of BD
7.13 Lifeline Scientific
7.13.1 Company profile
7.13.2 Representative Biobanking Product
7.13.3 Biobanking Sales, Revenue, Price and Gross Margin of Lifeline Scientific
7.14 Hamilton
7.14.1 Company profile
7.14.2 Representative Biobanking Product
7.14.3 Biobanking Sales, Revenue, Price and Gross Margin of Hamilton
7.15 So-Low
7.15.1 Company profile
7.15.2 Representative Biobanking Product
7.15.3 Biobanking Sales, Revenue, Price and Gross Margin of So-Low
7.16 TTP Labtech Ltd
7.17 Biolife Solutions
7.18 DNA Genotek
7.19 Custom Biogenic Systems
7.20 LVL Technologies
7.21 BioRep
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOBANKING
8.1 Industry Chain of Biobanking
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BIOBANKING
9.1 Cost Structure Analysis of Biobanking
9.2 Raw Materials Cost Analysis of Biobanking
9.3 Labor Cost Analysis of Biobanking
9.4 Manufacturing Expenses Analysis of Biobanking
CHAPTER 10 MARKETING STATUS ANALYSIS OF BIOBANKING
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Biobanking in This Report
1.2 Commercial Types of Biobanking
1.2.1 Equipment
1.2.2 Consumable
1.3 Downstream Application of Biobanking
1.3.1 Virtual Biobanks
1.3.2 Tissue Biobanks
1.3.3 Population Biobanks
1.4 Development History of Biobanking
1.5 Market Status and Trend of Biobanking 2013-2023
1.5.1 United States Biobanking Market Status and Trend 2013-2023
1.5.2 Regional Biobanking Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Biobanking in United States 2013-2017
2.2 Consumption Market of Biobanking in United States by Regions
2.2.1 Consumption Volume of Biobanking in United States by Regions
2.2.2 Revenue of Biobanking in United States by Regions
2.3 Market Analysis of Biobanking in United States by Regions
2.3.1 Market Analysis of Biobanking in New England 2013-2017
2.3.2 Market Analysis of Biobanking in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Biobanking in The Midwest 2013-2017
2.3.4 Market Analysis of Biobanking in The West 2013-2017
2.3.5 Market Analysis of Biobanking in The South 2013-2017
2.3.6 Market Analysis of Biobanking in Southwest 2013-2017
2.4 Market Development Forecast of Biobanking in United States 2018-2023
2.4.1 Market Development Forecast of Biobanking in United States 2018-2023
2.4.2 Market Development Forecast of Biobanking by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Biobanking in United States by Types
3.1.2 Revenue of Biobanking in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Biobanking in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Biobanking in United States by Downstream Industry
4.2 Demand Volume of Biobanking by Downstream Industry in Major Countries
4.2.1 Demand Volume of Biobanking by Downstream Industry in New England
4.2.2 Demand Volume of Biobanking by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Biobanking by Downstream Industry in The Midwest
4.2.4 Demand Volume of Biobanking by Downstream Industry in The West
4.2.5 Demand Volume of Biobanking by Downstream Industry in The South
4.2.6 Demand Volume of Biobanking by Downstream Industry in Southwest
4.3 Market Forecast of Biobanking in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BIOBANKING
5.1 United States Economy Situation and Trend Overview
5.2 Biobanking Downstream Industry Situation and Trend Overview
CHAPTER 6 BIOBANKING MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Biobanking in United States by Major Players
6.2 Revenue of Biobanking in United States by Major Players
6.3 Basic Information of Biobanking by Major Players
6.3.1 Headquarters Location and Established Time of Biobanking Major Players
6.3.2 Employees and Revenue Level of Biobanking Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BIOBANKING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Thermo Fisher
7.1.1 Company profile
7.1.2 Representative Biobanking Product
7.1.3 Biobanking Sales, Revenue, Price and Gross Margin of Thermo Fisher
7.2 Beckman Coulter
7.2.1 Company profile
7.2.2 Representative Biobanking Product
7.2.3 Biobanking Sales, Revenue, Price and Gross Margin of Beckman Coulter
7.3 Panasonic
7.3.1 Company profile
7.3.2 Representative Biobanking Product
7.3.3 Biobanking Sales, Revenue, Price and Gross Margin of Panasonic
7.4 SOL Group
7.4.1 Company profile
7.4.2 Representative Biobanking Product
7.4.3 Biobanking Sales, Revenue, Price and Gross Margin of SOL Group
7.5 Promega
7.5.1 Company profile
7.5.2 Representative Biobanking Product
7.5.3 Biobanking Sales, Revenue, Price and Gross Margin of Promega
7.6 Merck
7.6.1 Company profile
7.6.2 Representative Biobanking Product
7.6.3 Biobanking Sales, Revenue, Price and Gross Margin of Merck
7.7 Greiner Bio One
7.7.1 Company profile
7.7.2 Representative Biobanking Product
7.7.3 Biobanking Sales, Revenue, Price and Gross Margin of Greiner Bio One
7.8 Chart Industries
7.8.1 Company profile
7.8.2 Representative Biobanking Product
7.8.3 Biobanking Sales, Revenue, Price and Gross Margin of Chart Industries
7.9 Brooks Life Science
7.9.1 Company profile
7.9.2 Representative Biobanking Product
7.9.3 Biobanking Sales, Revenue, Price and Gross Margin of Brooks Life Science
7.10 Tecan Group
7.10.1 Company profile
7.10.2 Representative Biobanking Product
7.10.3 Biobanking Sales, Revenue, Price and Gross Margin of Tecan Group
7.11 QIAGEN
7.11.1 Company profile
7.11.2 Representative Biobanking Product
7.11.3 Biobanking Sales, Revenue, Price and Gross Margin of QIAGEN
7.12 BD
7.12.1 Company profile
7.12.2 Representative Biobanking Product
7.12.3 Biobanking Sales, Revenue, Price and Gross Margin of BD
7.13 Lifeline Scientific
7.13.1 Company profile
7.13.2 Representative Biobanking Product
7.13.3 Biobanking Sales, Revenue, Price and Gross Margin of Lifeline Scientific
7.14 Hamilton
7.14.1 Company profile
7.14.2 Representative Biobanking Product
7.14.3 Biobanking Sales, Revenue, Price and Gross Margin of Hamilton
7.15 So-Low
7.15.1 Company profile
7.15.2 Representative Biobanking Product
7.15.3 Biobanking Sales, Revenue, Price and Gross Margin of So-Low
7.16 TTP Labtech Ltd
7.17 Biolife Solutions
7.18 DNA Genotek
7.19 Custom Biogenic Systems
7.20 LVL Technologies
7.21 BioRep
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOBANKING
8.1 Industry Chain of Biobanking
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BIOBANKING
9.1 Cost Structure Analysis of Biobanking
9.2 Raw Materials Cost Analysis of Biobanking
9.3 Labor Cost Analysis of Biobanking
9.4 Manufacturing Expenses Analysis of Biobanking
CHAPTER 10 MARKETING STATUS ANALYSIS OF BIOBANKING
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
